Thoracic surgeon at the University of Chicago @UChicagoCTSurg. @BrighamThoracic @uchicagosurgery @MacLeanEthics alum. Husband of/inspired by: @avafbryan
@JackWestMD@BrendonStilesMD Big fan the term “aspirationally resectable”
And, agree. Need to focus on meeting current standards for high quality lung cancer surgery. But as a field, we should still have certain people pushing the boundaries. Doing so shouldn’t distract from high quality surgery, everywhere
Aren’t You the Valet? Tales of Black American Surgeons | NEJM Today, in the US, it is as if there are 2 different scripts being loudly declaimed trying to drown each other out. The escalating chant “BLM” is countered by … cancel culture & White supremacy. https://t.co/3VKmh4OD5H
Thank you for sharing your experience!
Hearing my patients’ stories over the years during surveillance has led me to believe (even though i cannot prove) that PFTs have value in risk-stratification, but they do not predict patient experience.
Delighted to announce MARS 2 data is now mature and we aim to report this year! Thank you to our patients, UK investigators, @BrsTrialsCentre, @NIHRresearch@CRUKresearch for 7 years of hard work!!
AUDARA update with longer F/U but OS data still withheld https://t.co/msig4NFFKL
Interesting👀 Brain mets incidence starts to rise AFTER 3 years osi is up in stage II/IIIA while in control group it plateaus at ~10%. So does osi really only delay recurrence?🧐
Do we need MRIs???
Importantly, for clinical relevance, we show that we can predict recurrence after surgery in a cohort of Stage 1A-B lung cancer patients by using machine learning and as a result can inform on adjuvant treatment strategies. We don’t need 35 markers- we can do this with just 6! 🙌🏼
@esinghimd @ADesaiMD@FDAOncology @DrSteveMartin @n8pennell@JackWestMD Here’s some help: just do neoadj and you’ll hardly ever have to think about this adj business. The real question is whether there’s value in adj IO for patients who received neoadj chemo-IO. That’s the real question for which we will soon have some useful data. #LCSM
I am incredibly appreciative to be at an institution that values diversity and equity. I am proud of the work we do to combat structural racism and improve access to care. @UChicagosurgery promotes a positive and inclusive environment
Issue Information ‐ TOC https://t.co/d31LzCcDmc
This month's issue of JSO puts the spotlight on thoracic oncology and our own Dr. Mike Jacklitsch @BrighamSurgery@BrighamThoracic